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ABSTRACT 
Several known trans-splicing RNA structures were used 
to define a canonical trans-splicing structure which was 
then used to perform a computer search of the EMBL 
nucleotide database. In addition to most known trans-
splicing structures, many putative new trans-splicing 
sites were detected. These were found in a broad range 
of organisms Including the vertebrates. Control 
experiments indicate that the search predicts known 
false positives at a rate of only 20%. Trans-splicing may 
therefore be a very wide-spread phenomenon. 
INTRODUCTION 
When trans-splicing of pre-rnRNA in trypanosomes was first 
reported [1] it was viewed as yet another peculiarity in an group 
of organisms already known to be atypical [2]. (For reviews of 
trans-splicing see [3 -7].) The subsequent discovery of trans-
splicing in chloroplasts [8-14] and nematodes [7] indicated that 
the phenomenon was much more widespread. Naturally the 
question arises; how widespread is trans-splicing? This question 
is enticing not only for academic reasons. As Boothyroyd [15] 
has pointed out, many drugs that might control parasitic 
trypanosomes or nematodes also injure the host. If trans-splicing 
were to occur only in certain groups of organisms, (and 
particularly not in humans or cattle) then the trans-splicing 
reaction might provide an ideal target for novel drug therapies. 
The answer would of course also provide insight into the the more 
fundamental question of the evolution of trans and other forms 
of splicing [6]. 
While the 5' mini-exon that is trans-spliced in kinetoplastids 
is sufficiently conserved [16] that it was possible to biochemically 
locate 'CrithidiaJascuculata mini-exons using aT. Brucei probe 
[17], there is sufficient divergence between the mini-exon 
sequences of nematodes and trypanosomes [18] to prevent the 
location of nematode mini-exons using the same methodology. 
In general for phylogenetically distant species (which are the 
interesting ones) it will not be possible to use a mini-exon probe 
to biochemically screen novel species as a way of discovering 
if they also trans-splice. Since it is possible to identify eis-splicing 
sites using computer searches [19], it seemed that such an 
approach might also be used to locate trans-splicing sites. Studies 
on the mechanism of trans-splicing have identified many 
important features of trans-splicing RNA structures [6, 20]. By 
using such features to search DNA sequence data bases, we have 
been able to detect new putative trans-splicing sites and present 
evidence that trans-splicing occurs in organisms not previously 
known to exhibit trans-splicing. 
MATERIALS AND METHODS 
The EMBL nucleotide sequence database 22.0 [21] consisting 
of 38 X 106 base pairs and 32 x 103 sequences was used. 
Searches of both strands were performed on the EMBL V AX 
cluster using Pascal programs custom-written by one of us (TD) 
for the purpose. 
The target for which to search was derived from the six trans-
splicing structures shown in Fig. 1. These structures were chosen 
because they are well documented [20] and relatively well 
understood. The canonical structure which was used as the target 
is shown schematically in Fig. 2. Features which were deemed 
obligatory were (1) the G-G doublet pairing with the Y -Y doublet; 
(2) a loop size of 3 - 10 nucleotides of which at least 3 must be 
U; (3) of the 4 positions following the G-G doublet, at least 3 
of them must base pair with the opposite strand (here and 
elsewhere G:U is considered a pair). If 1,2 and 3 pair then the 
stem is extended until only 50% of the bases (including positions 
1,2 and 3) pair. If one of 1,2 or 3 do not pair then the stem is 
extended until a non-pair is encountered. (4) The distance ranges, 
0-7 bases are obligatory. (5) The Srn-site consists of a stretch 
of at least 3 U interrupted by 0 or 1 other nuc1eotides, bracketed 
at both ends by the doublet R-R. The first nucleotide of the Sm-
site had to be within 60 nucleotides of the trans-splicing loop. 
(6) Stem loops I and 11 were identified with a simple energy 
scoring scheme. Each G:C pair scored 3, A:U scored 2, G:U 
scored 1, and non-pairs scored - 2. A one nucleotide bulge was 
permitted and scored -2. The resultant energy sum had to exceed 
both 6 and (the number of nucleotides in the stem plus loop 
divided by 2, rounded down to the preceding integer). 
Non-obligatory target features also contributed to the evaluation 
of putative hits (a hit is a positive located by a search). Each 
of the following seven possible features contributed one point; 
(1) the first residue after the G-G is a U; (2) the second residue 
is an A; (3) on the the other strand of the stem the 5' most residue 
should be G or U; (4) the 3' adjacent residue is a U (5,6) the 
next two 3' adjacent residues are A or U; (7) there was no 
constraint on the next 3' adjacent residue, but the one after should 
be a U. At least 6 of the 7 non-obligatory features were required. 
Note that the stem labelled as 'non-obligatory features' may 
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Figure 1. The 6 trans-splicing structures used to build the canonical structure, 
redrawn from [20) . These structures have been described in detail as follows , 
Caenorhabiditis elegans [18), Trypanosoma crnzi [16), Crithidiafasciculata [17], 
LeptOmofUlS collosoma [1), Trypanosoma vivlU [16], LeptOmofUlS enrietti [29). 
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Figure 2. The canonical truns-splicing structure that was used as a target to perfonn 
searches. See Materials and Methods for details. 
overlap with positions labelled 1 to 4 ( and its complementary 
strand) but the two have been drawn as non overlapping in the 
interests of clarity. 
RESULTS AND DISCUSSION 
There were 327 hits with 6 of the obligatory features and 37 hits 
with all 7. The distribution of the hits in various groups of 
organisms is summarized in Table 1. Detailed infonnation about 
each individual putative trans-splicing site is presented in Table 
2. Trans-splicing sites are predicted both in introns and exons 
with a trend to have more intron examples in higher organisms. 
Most sites are either known to be transcribed as RNA (EX, IN, 
LT in table 2a and 2b; on (C) in Table 2b) or to exist as RNA 
as part of their life cycle (labeled as int in Table 2). It has been 
proposed that the DNA strand opposite a coding sequence also 
may often be transcribed [22] and many predicted trans-splicing 
sites are opposite CDS (Table 2). 
Controls 
Of the six sequences shown in Fig.l (those used to build the 
canonical structure) the five stored in the EMBL database were 
correctly identified and had all 7 non-obligatory structures (L. 
enrietti was not stored in the database as an unsplit motif.) . In 
addition, several other known trans-splicing RNAs which were 
not part of the training set were correctly identified: LSMEDRNA 
(all idcodes refer to the EMBL database) and LSILINSl from 
Leptonwnns seynwuri, TRSLRC and KTKPMC02 from T. cruzi; 
ALRLASL from Ascaris lumbricoides; CBRR5B, CBRR5A from 
Caenorhabditis briggsae; and CERR5 from Caenorhabditis 
elegans. In addition, numerous sites were identified in 
chloroplasts (Table 2) in which trans-splicing is known to occur 
[8-14]. All the known trans-splicing organisms including 
trypanosomes, Nematodes and Chloroplasts are correctly found 
by the search, usually with a score of 6 or 7. However, some 
trans-splicing sites were not found and these are discussed next. 
Trans-splicing RNAs from TrypanosolrUl brucei which have 
a diverged Srn-site, RRTCTRR [1] are not found (although 
KTKPCYB from T. brucei with a canonical Srn-site is found, 
Table 2). Use of the diverged T. brucei Srn-site makes the search 
quite non-specific (data not shown). Apart from this, trans-splice 
sites that are interrupted by introns, e.g. TCMXA or stored in 
the database as two or more parts such that the trans-splicing 
motif is split (e.g. L. enrietti , LESLl ) are also not detected. 
Similarly, in some cases the GG of the trans-splicing structure 
is in the database but the up or down stream sequence does not 
appear in the sequence entry (e.g., CFMIEX, see also TCSLGB 
and TCSLGA which stop at the first G). As would be expected, 
such 'truncated' sequences are not identified by the search. Finally 
there are some known trans-splicing RNAs for which the exact 
site is not known experimentally and the search should allocate 
a splice site for these. Rpsl2 RNA in tobacco found by Koller 
et al. [12] to be trans-spliced, was missed. However a site was 
correctly predicted for the known trans-splicing of rpsl2 in 
liverwort; i.e., a site with 5 non-obligatory features is located 
268 bases after rpI20 / rps12 exonl on the complementary strand 
at base 65539 in a long transcript [23] . In Chlamydonwnas 
reinhardii psbB is known to trans-splice [13] but the search does 
not find a trans-splicing site. However the search does predict 
a trans-splicing site in psbC with 5 of the non-obligatory sites. 
Moreover, a trans-splicing site (with all 7 non-obligatory features) 
occurs in the Liverwort plastid at 42738, 14 base pairs upstream 
of psbB and another site occurs with 5 non-obligatory features 
in psbB (C) in tobacco at 39201. Four other sites in C. reinhardii 
have also 5 of the non-obligatory features and thus are excluded 
from Table 2 (only hits with 6 or 7 of the non-obligatory sites 
are presented). A complete list of the search results including 
hits with 5 of the non-obligatory features is available on request 
from TD. If the hits with a score of five are included, the search 
identifies all genera known to trans-splice which are stored as 
a complete motif in the data base. From chloroplasts it is known 
that both complete exons and small leader sequences are trans-
spliced. Thus we did not restrict our search by demanding an 
additional homology to the small spliced leader as this hampers 
the identification of known chloroplast sites (data not shown). 
Table 1 indicates considerable variation in the number of 
predicted sites per 106 base pairs. From this it is tempting to 
conclude that trans-splicing is much more likely to occur in 
organelles, invertebrates and fungi than in the other groups. 
Caution is needed in making any such interpretation due to the 
presence of confounding factors. In particular, trypanosomes 
Nucleic Acids Research, Vol. 18, No. 16 4721 
Table l. The occurance of hits in various categories of DNA in EMBL 22.0. This database is divided, approximately along 
taxonomic lines. but primarily for convenience, into the categories: synthetic, viral , phage, organelles, prokaryotic. fungi , 
invertebrates. plants. vertebrates, mammals, rodents, primates, and unannotated. This Table shows the frequency of occurance 
of hits with 6 or 7 of the non-obligatory positions (strong positives) in each category. The total amount of DNA in base pairs 
and the number of sequences in each category are also shown. The rightmost column is the number of hits (6+ 7) per lO's'up3(6) 
base pairs. 
Category 
synthetic 
viral 
phage 
organelle 
prokaryote 
fungi 
invertebrate 
plant 
vertebrate 
mammal 
rodent 
primate 
unannotated 
total 
sequences 
755 
2762 
512 
1550 
3765 
1455 
2251 
1462 
1563 
I 172 
5591 
5466 
3195 
31 508 
base pairs 
274405 
4502866 
613 323 
2 191 964 
5 301 864 
2 143 702 
2714876 
1988708 
1794464 
1468528 
5763874 
6664 208 
2 811 783 
38234565 
Table 2a. Putative splicing sites from the strand provided in EMBL 22.0. Each 
category of DNA is headed by the name of the category followed by the 
percentage of the database which the category constitutes, followed by the 
percentage of the total hits, followed by the ratio. This provides a course estimate 
of how frequent lrans-splicing sites are relative to the amount of DNA being 
searched. After the heading the format is: EMBL idcode, position of GG in 
bases from the 5' end of the sequence (counting only a,u,c,g,t), sequence title 
(which may have been abbreviated), and comments. Between the idcode and 
the position an asterisk ,* , indicates that all 7 of the nonobligatory features 
were found and that, as a consequence, this is a strong candidate for a frans-
splicing structure. The absence of an asterisk means that 6 of the nonobligatory 
features occurred. If the same sequence is cited in several data base entries , 
their idcodes are given directly after the sequence title. The following conven-
tions were used for the comments: rep = repetitive DNA; GG: means the splice 
site is found exactly at the 5' guanosine of the catalytical Guanosine doublette; 
test indicates that the trans-splice site is one of the ones used to build the canonical 
structure; ntst indicates a known frans-splicing RNA not from test set; knownO 
means that the organism is known to possess the frans-splicing reaction; knownS: 
known splice site; int : close to integration events; invA: before chloroplast in-
verted repeat A; ptRNA: near tRNAs ; cytB = in cytochrome B; cox: in 
cytochrome oxidase subunit I; PKC = protein kinase C; ori = origine of replica-
tion; nuc = nucleoline; km = kanamycine resistance; EX (ORF number): exon 
(open reading frame , number) ; IN (letter): intron(number) ; dn: after transla-
tion but before polyadenylation; pa : after polyadenylation site; ig: intergenic, 
no transcription unit. Fint .FinvA,FmRNA ,F: five prime of int, invA, start of 
mRNA transcription; LT denotes a long RNA transcript occurring 3' from the 
trans-splicing site. For references to individual sequences and annotation, refer 
to the EMBL database (Cameron 1988). 
________________________ ,Synthetic ____________________ _ 
£CRGNABP 604 &. coli rrn promotor/terminator fu~ion i9 
_________________________ Viruses ____________________ _ 
CORlBA$P 5450 .... vian infectious bronchitis vi rus 
EBJNCl 244 Epstein-Barr integration; 
HSSWTl 244 Epstein-Barr int~ration: 
HANSNC 331 HAnt.an virus nucleocapsid protein 
HEHSLTA 119 Herpes atoles thymidyhte synthase 
HEHSSTS 469 Herpes saimiri thymidylate synthase 
HEVZVXX 68271 Varicella-Zost.er virus (95124 272T up, 
NCBNYVV) 3408 Beet Necrotic Yellow Vein Virus RN.-.-) 
PA16 6391 Human papillomavirus type 16 (HPV)6) 
PAPPPHJ) 410J Human p.pillomAvirus type 31 (HPV-3I, 
mid EX 
int 360T Fine 
int 360T Fint. 
mid EX 
int 142T FaRNA 
int l02T ~A 
32ST EX 
mid EX 
mid EX 
mid EX 
__ --------________________ P.094" ____________________ _ 
fusion 
LT 
I.T 
LT 
LT 
LT 
LT 
INPF3COl 1884 a.cteriophaqe pt]; INewYork strain) 801" EX QRF 93 
INPf)COM 1884 IHijuegen strain) 80r EX ORr 93 
pop22INT 373 La.lIOdoid phage P22 int-d,s reqion i9 
6 point hits 
I 
7 point hits 
o 
hitsll ()6bp 
4 
23 
3 
52 
30 
31 
33 
18 
14 
6 
32 
57 
27 
327 
I 
I 
16 
I 
o 
7 
I 
o 
o 
3 
6 
I 
37 
5 
7 
31 
6 
14 
15 
10 
8 
4 
6 
10 
10 
10 
______________________ 'Orq.nel1e. ____________________ _ 
ALCRDNA 3~92 
CFRPHE 416 
CHEGS16R 2217 
CHHVPSBD 3221 
CKMPXX 69971 
CHMPXX 71381 
CHHPXX 109520 
CHNt'XX 60343 
CHNTXX 130104 
CHOSXX 99488 
CHSARS16 166 
CHTATRNl 3lf.i 
CHZKRN4 28 
KTKPCYB 508 
Kl1'BOl 1100 
KTKPHC02 609 
LSMEDRNA 460 
LSLINSl; 182 
HIBSRNAL 118 
HlCAARS 1272 
HIDHURFV 68 
MIDYTRN 1173 
MILTRRNG 525 
MINCN'D 260 
HIPRGPL 3053 
MISCl) 1855 
HISC23 ; 522 
HISCC01; 522 
Ast..,si. 10nq. chloropl .. :st ribo.s .OHA 
C. hscicu1 .. t .. ILini-...:on repe.t 
Euqlen. qr.c. chlorop1 .. st rRNA dupl. 
&.rley chloropl.st. psb8~ H;peta, D 
Liverwort Ha.rchantia chloroplast 
(12 Trans5) 
(998)1 iql 
Tobacco chloropl.st; (5 TransS) 
(1S2057 pt.RNA, iql 
Rice cOllPlete chloroplast qeno~ 
mustard chloroplast rpsl6 qene 
Wheat chloroplast, URF62, 5t.RNA genes 
Maize Arq- .nd. Asn-tRHA 3' re9ion 
T. brucei ltplast "pocyt. b 
T .cruzi kplast ca.inicircle DNA pTc-21 
Leptom. seymouri m.ini-exon 
• mni exon with in .. rt. element LINSl 
Boletus sat.naa at l.rg-e rRNA gene 
Cephalosporium .cremonium mDNA ARS 
D . virilis aitochondrial DNA rRNA/UIlF 
D. yakuba aitochondrial DHA 
Leishmania tarentohe IIlt.DNA (12S rRNA) 
NClurospora crass ... tlADH dehydr. ase 
P. primaurelia lilt. rDNA; 3053; 30S3; 
yeast cytochrome oxidase subunitl 
.3 above 
as above 
iq, not in rRHA 
test GG control 
int 01' int 2 
cyt8 201' up LT,600 
psb8 581 T EX 1 ItnownO 
cytB 431' up knownO 
invA 1401' FinvA knowno 
558F EX ON" 512 knownO 
invA "'001' FinvA knownO 
"'001" dn ON" 23 
2901' up LT 
ptRHA,EX URF62~LT~notel 
ptRNA 19 
EX, nota2, knownO 
£x~ not.e2, knownO 
ntst 
ntat 
ntat 
EX 
GG 
GG 
GG 
ori i9 
knownS 
knownS 
knovnS 
GG exactly at boundary 
ori iq 
90F EX 
NAOH 1601' up LT, not.7 
ori 1'1 
cox1 mid IN.I4 text 
HISPXX 5991 Sea urchin rnt genome (Trans5 in HADH, coxl 210F EX 
HITGTRNl 196 Torulopsis qlabrat. _ UlNA qenes 
SCMTOR1A SI Yeast (petit.e) Iflt. replication origin 
TCMIEXl JS Tryp.nosoma cruai ..uni-exon repeat. 
TRSLRC 80 T. cruzi s .. 11 spliced leader 
TRSLRLC 17 T.LeptOJll. colI. anui.ll aplic. 1 •• der 
pt.ItNA 
ori 
t.at 
ntat 
teat 
i9 
i9 
GG 
GG 
GG 
control 
Itn<*nS 
control 
__ ___________________ ,Prot.ryotea, __________________ _ 
ASCHMO 61 Acinet.ob41cter cycclohexanone monooxY9 . 3271' F'IIIRHA 
ATACHS 18611 A.tumetaciens ph:nlud pTilS9S5 T-DNA 
BSPRBHIK 1510 Thenrr.. b.acillus phs-.i.d pRaHl (km) 
CTORF 2231 C. trachoa.at.is pl.said pCTTl; CTDNAB; 
ECBlRA 60 E.coli biotin birA gene 
ECCPELC 418 Er", i ni. caratovora .ndo-pectate lyase 
ECOKS 6146 E.coli .naerobic di_. sulfoxide red. 
ECRRNBZ 6674 E. coli 165 rRHA, tRNA .nd two urts 
HIOMPP6 S]5 H. influeoz.e outer .eMbrane protein p6 
HVHCRl 2932 Hethanoc. volta. rDethyl-CoH reductase 
PHMB66EH 295 Plasmic1 pMMB66EH expression vector 
PSIRH 498 P. stuartii pst! genes 
SAll0KAR 1510 S.aureus plaallLid pUBllOdS (kin) 
SAP5l94 197 S.aureus plasmid pS194 
54T EX ORF23 not .... 
k.na 123F EX 
aid EX ORF2 
238T .. ~ 
31T FmRHA 
i9 
i9 
i9 
228F EX 
19 
i9 
Iua l23F EX 
i9 
LT 
LT 
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SMTRNAl 389 Spiroph.sma _lilerue. tRNAs ; 389; 
SPLYTPN 131 S.pneumoniae autolysin gene 
GG at S ' tRNA 
61T r.aRNA 
note3 
VHCHIT 3179 V. harveyi N,N'-dhcetylehitobiase; i9,16 bp 3' of 29 bp hairpin 
__________________________ ~Fun9i __________________ __ 
CAERG16 322 Candida albicans cytocbra.e p-4S0 LIAl 187F EX 
KLGAL 
KLKIP 
fl:LJl:tP 
SCDELl 
SCDP8 
SCKAP2 
3997 Itluyveromyce" lae. GALl. GAL' And GALIO 269F EX (;«11 
3830 Kluyv . lacti" killer plaslllid kl 400F EX ORf't 
6365 (killer toxin is ORYI); KLlClLLOS, KLKILLIL: lS0T EX ORYI 
185 Yeast delta and trunc.at<ed delta element int IIlid iot 
908 Yeast. delt.a-P8 gene S· region 
4.3 Yeast transcriptional activator HAP2 
aid EX 
91T up 
SCHOHHT 121 Yeast nuel.fllr dna hO&llOlog-ous to mt dn. 
SCRPS31 935 Ye",,:t. gene for riboaocul protein 531 
ig 
120T EX 
604F pa 
383F EX 
note 10 
SPM£I2 3318 S.polDbe _i2 gene 
SPTUBAl 164 S.pombe alpha-tubulin 1 
___________________________ ,P1.nt. __________________ __ 
GHGY3 2466 Soybean glycinin subunit G3 gene HOr IN 3 
GHTGMl 21~2 Soybean lectin transposon Tqml 
LECHSOD 134 To..t.o auperoxide disautase rRRNA 
int SOOT int PI 
1021' EX 
LT 
LHOEL GG exac tly at the STOP of exon 
HepPeS 1801 H . crystaUinwa phoapboenolpyrcarb . 
PSLECPGA 225 Pe. PSL2 lectin pseudOCJene 
STPATPl 4900 Potato p.uatin pseudogene (S868) 
STPATP2 5964 Potato patatin p •• udoqene (SAIOC) 
STWIN12G 3431 PoUto wound-induced ~nes WIN2 
tMCPPS2G 25 Maize chloroplast psbG gene 
tHZEIl9 3206 Haize gene for Hr 19000 alpha :tein 
mid IN 3 
int IO.i.d int 
int au.d int 
int aid int 
300T mRHA 
1301 up 
541' pa 
_____________________ Invertebrates __________________ _ 
ALRGASL $44· A. lumbricoides spliced leader 
BHeHOl 861 silluDoth chorion protein Hc-B.13 
BHCHRHCA 1145 silkmoth chorion protein HC-A.12/B.12 
CBRR5B 
CEACTL 
336 Caenorhabditis briqq.ae 5S rRNA 
352 C . elegans actin spliced leader 
DHKIF8A 3817 Drosophila hydei Ifticrocopia dhHiF8 
OMGPDKA 3902 Drosophila GP-dehydrogenase; DHGPDHG 
OHWHITE 13867 Drosophila white locus 
NGRGE 199 N.gruberi 18S subunit. rRNA gene 
ntst 
ntst 
test 
GC k.no wnS 
mid EX 
189F EX 2 
G<'i knownS 
GG control 
661F pili 
68T IN 
i9 
802F EX 
I iq 
PCTHYSY 1267 P.cadoii thymidylater synthase gene GO is exactly at EX4/IN D 
PFANT2L 409 P. falciparum antigenic: determinant 30T up 
int mid int 
note9 
1361 P. tAleiparum repetitive DNA PFRSI 
PFTRAP 266 P.blciparum thrombospondin rel . prot. JOT up 
200F IN 5 
note9 
TTCNJB 2114 Tet.r&h~na therlDOphih cnja gene 
TYMIEX1 35 Tryp«nosOllle viva. aini-exon repeat. test GG control 
______________________ Vertebrates ________________ __ 
CIACTS 3965 Grass carp beta-actin gene 6431' dn 
GGE.F9E3 898 Chicken embryo libroblast protein mRNA 284T dn LT 
GGMl'C 3384 Chicken c:ellular aryc onc . qene;GGCHYCA mid IN 2 
GGHYHE 8908 Chicken Ulbryonic myosin heavy chain GG exactly at IN13/EX14 
GGPGR 4270 Chicken proqe:sterone rec eptor mRNA 30T <in 
GGRSVIND 87B Chicken RSV-tranaformed mRNA 400T <in 
XLENK02 40 Xenopus bevls proenkephalin gene A2 561' IN 1 
XLLAHLI 2366 Xenopus mRNA for nuclear la.rn.in LU) lOOT dn 
__________________________ ~HamMls ________________ ___ 
CH£8GLIJ 1019 Goat .pallon II bet.-globin gene 90F IN 2 
OCPKc9R 2231 .... bbit protein kinase C beta JIlRHA PKC 1F dn 
___________________________ '~nt. __________________ _ 
DOREPI 2178 Kangaroo rat repetitive DNA; 2179: int 516T int LT 
MAHPRT 1083 Chinese haast.er hprt arna 60T do 
MM8GLOFG 45 Hous. down.tre .. ot beta-qlobin gene 600F Pill LT 
MKDHf'4 
MHDHFl 
181 Mouse autant tetrahydrofol . -OH mRNA 
325 House dihydrotolate reductase exon3 
HHETNB 2272 Hous.e early transposon (ETn) 
KMIRFl 2 2192 House interferon rag. hctor-2 ~ 
HMNUCLOl 1906 House nuc1eolin 98ne ; HHHUCL£O; 
HMPPI05R 3880 Mouse retinoblastoma susceptib . ; 3885; 
KHT1CPS 2003 House TIc pseudoqene for MHCI antigen 
RNCAHI3 1915 Rat CaMI gene for calm04ulin 
RNFBAG 3420 RAt. gene for alpha-fibrinogen 
RNNUCLEO 2064 Rat nucleolin gene, exons 1 and 2 
RNPECOA 1509 Rn. peroxisoaal enoy1-CoA mRNA 
RSLIN4A 3033 ~t. long int.erspersed repet. . DNA 
150T dn 
lOT IN 2,near EX 
int 30T Fint. 
243T dn LT 
nuc 290r IN 1 
1020F dn 
239r IN 3 
mid IN 
573T IN 1 
n ue 290T IN I 
578T EX 
into mid int 
_________ Primates (all hit.. are bWillY.n) __________________ _ 
HSB2H2 2113 Hwoan beta-2-r:o.icroqlobulin gene 103T IN 3 
HSC1Al 2428 Human Alpha 1 eollagen type I gene 56r IN E 
HSCRPG 1930 Human C-r.active protein; KSCRPGA: 500T do 
HSEB2CR2 3943 EBV rec.ptor er2 RNA; HS£8UR14 : HSEBVR. ; lOOr do 
HSFIBEDA 2718 fibronect.in qene EO-A reqion; 2719 27BT IN 2 not.e6 
HSGA7331 1691 pancreas CA earker -.RNA GA,133-1;HSGA133A; 102T dn 
HSGASTB 479 Human gastrin gene, 3' region 
HSHBEG 8493 Human LIHeg repetitive el_nt 
HSHBVINT 314 Human DKA. I hepat.itis B virus inteqr . 
HSHK2A 3726· Hwu.n calciUlll-ATPase BUfA;HSCAATP4 ; 
HSHHG14 650 non-histone protein HMG-14 mRNA 
HSHM.GCOB 1140 HHG CoA reductase (EX1 and promoter) 
HSHSP90s 3862 • Human 90 kD heat 8hock protein 
HSHTV2A 1028 Hwun t.RMA-VA1 futily 
HSIFN83 11512 Human interferon- beta-3 lOCus 
HSIGVKA2 1910 19-kapP. V(k) III pseudoqene A22 
HSINSRC 5420 Human insulin receptor allele 1; 5420 ; 
HSINSRO 5019 Human insulin recept.or allele 2; 5019; 
HSIRF2 1947 interferon requlatory f.cto~-2 mRNA 
HSMHDRW1 2246 MHC class II HLA-OR"'S3-beta 
H$PKCB1A 2152 protein kinase C beta I IIIRNA: HSPKC81: 
HSPROL1 478 Hwu,n prOlactin 9.ne 5' region 
HSRBS 3976 Hwun ret i noblastoma .use.ptib . IrIRHA 
KSR~KPOB 311 Hwnan kpni repeat I¥lrn. 
400F pa 
int mid int 
int 600r rint 
55T do 
190F do 
mid IN 1 
23.r IN D 
pt.RNA lOOT FtRNA 
i9 
1501' IN 1 
LT 
LT 
LT 
124T IN 0 NoteS 
724T IN 0 NoteS 
1971 dn 
1200' IN 1 
PKC GG at STOP Codon 
400T up 
600F dn not.8 
int mid into 
HSTCGVA5 1044 T-cell recaptor pseudo;ene; H5TCGVA: GG at known splice site 
HSU6RNA 152 HWMn 98n. for U 6 RNA lnt UT upstream of u6 
notel: Lon.; ~A, tran:scribed toqether with precedinq psbC and pSbD. 
Cleanqe at tho GC would yield a thylacoid membrane .pannin9 peptide . 
note2: Lonq mRNA; .pocyt..b RNA b split and splic:ed in aspergillus and yeast.; 
The URF:s surrounding T . bruc:ei apocyt . black polyadenylation s1gnals, but 
there i s an A-ric:h sequence .at the 3 'end ot a cDNA found by URF2 probe. 
note3 ; The 10 bp up~t.reaJll, ot tRNA Pro together with the tR.NA Pro form a TRANS6 
which exact. l y releases S'ond tRNA Pro from the lonq five t.RNA precursor. 
not.e4: The TRANS starts lit. bp 18616 and ends exactly at th. end ot ORF (bp18687) . 
noteS: The t.wo alleles have slightly different. TRANS, but. at the aalM position. 
not.e6: £X2 before 1N2 ia "ntranslated in liver and alternatively apliced mRNAs 
with and wi thout Ex2 occur in different ratio. in ditterent tissue •. 
note7: Longer RNA species ot 5, 5.6 and 7 kb are only lit by probe • . 5' to the 
nd4L gene or exon probes but not by intron or downstream probe •. 
not..a: A tuns-splicin9 event would lead t.o t.he shortened 4 kb ftIRNA observed in 
retinoblastOJDes. 
note9: IdentiCAl positions. Parasite under genetic pre.sur. lik. Trypanoaome.! 
notel0:Ent.ire 3'eno (128 bp) ot protein 531 mRNA torms a trana-aplicing RNA . 
Table b. Trans-splicing sites from the strand complementary to that given in 
EMBL 22 .0. The position is where the GG occurs in terms of the strand given 
in EMBL 22 .0; it is not the distance from the 5' end of the complementary 
strand . Legend, as in Table 2a with the addition that CDS is coding sequence 
and opp means opposite from the strand searched. On (C) means that the 
transcription unit is here, on the complementary strand. 
_________ ,Synthetic (no hits } ___________________ ___ 
___________ Viruses ________________________________ _ 
~DLE28 1'... Adenovi["us type 12 E2b reqion DN~ 
lRltPEH 1190 Insect iridescent virus type 6 
PXVACLEM 805 Va c ciniA viru:s transpoaition mutant 
REHULVT3 441 Murine leukaeraia virus CHuLV) 3'LTR 
REMULVT5 432 Hurine Leukeaia virus (H"LV) 5' LTR 
RESPUENV 311 Hwun spuzuretrovirus 
COTGEV3 2941 Ent.eric coronavirus 
CORTGEVM 1020 Enteric coronavirus 
HRVVp2 864 Hwnan rotavirus 
PARPVCOl 3471 Canine parvovirus 
PARPVCCP 419 Canine parvovirus 
P~R.PVCVP 1799 Canine parvovirus 
MCACGDH 64 CauliflOW4llr .,~aic virus 
VSVNJNPA 195 Vesicular stOlUtitis virus N protein 
pol rtdd EX 
<ep 
1nt 
~et~ovicus 
retl:ovirus 
retrovirus 
on (C) 
opp non-struc t.r. pr-otein 
opp nucleo capsid p~otein 
opp vp2 
opp vp2 
opp CDS 
opp COS 
________ Phaqes _______________________________ _ 
HYOVP1 
STSP02 
$42 Bacteriophage PI IS2 inJlertion hot spot. int 211' ORFl on (C' 
486 Bacteriophaqe SPOl with tenn.a.nal repeat GG start VC qp28 on(C) 
_____ ---'Orqanelles, ______________ _ 
CHCERR23 759 ChIoreHa ellipsoidea phstid lnt Tn like sequence 
CHMPTRN 2960· Liverwort Marchanth. plastid: knownO mid EX ORF 104 on (C) 
CHHPXX 46949 tiverwert Marchantia plastid; knownO 250F EX pSaA on (C) 
CHHPXX 30611 knownO 
CHHPXX 42738" very good. candidate!! knownO HF EX p:saB on (C) 
CHOSXX 115630 Rice complete chloroplast genome between ORF63 and ORF23 on (C) 
CHOSXX 103186 Rice complete chloroplast genome 
CHOSXX 49441 Rice complet.e chloroplast genome 
CHZMNDHD 263 Maize chloroplast ndhD, ndhE and psaC 
H10l1HZ 124 .. D.melanoqaster mt large rrna gene; 
HIDHTRN 1361" Drosophila mt DNA; 
HIDYRRN 15258 Ocosophila yakuba mt DNA 
HIHMOl 1415 House !lltONA 
HINCN02D 801 "',u·oapora cra3sa mt DNA duplications 
HIPAIVS2 961 Podospou an •• rin. class It intron 
HIRC12S 1869 ~n. catesbei.n •• tDMA 
MIRNRN 280 IUot _tDMA; MIRNXX 
MIsel3 2283 Y.ast cytochrome oxict.s. subunit 1 
HISCC012 2656 Y.ast. cytochrome oxil gene and flank.:s 
NADH 451F EX NOS on (C) 
MADH 221F EX N03 on(C) 
NADH 
GG at I1T EX onCC) 
NADH 24F EX NOl on (C) 
ori 
259F opposite 16S rRNA 
int 259F NAOH duplicat 
int homologous to RT 
988T opposite 16s rRNA 
255F opposite 16S rRNA 
coxl 
coxl 
HISCORIK 281 Yeast mitochondrial ori2-ori 1 region ori 
HITBCOX 1903 TryPAnosoma brucei lilt cyt c oxidase 82F EX ontC) 
HITOMH 1351 House IIli.tochondrial qenome 
MITOMH 10410 House IIlitochondrion 
2S1F opposite 165 rRNA 
opp URF4 
MIXLG 3343 Xenopus laevis mt qenome 
HIXLORI 866 X.laevis et od 
XLHTOTG 251F opposite 165 rRNA 
ori 
CHNTXX 90412 Tobacco plastid knownO 
HIBTXX 4916 Bovine mitochondrion 
TBGPOl 511 T .brucei surface protein 
______ Prokaryotes _____________ _ 
BAAPR 322 • B. amyloliquifaciens alk. protease 
BSPRBH1K 198 TheODOphile kanamycin plasmid between reps 
BSREPB 198 Bacillus plasmid 
BSROOC 3662 Bacillus subtilia rodC operon 
ECCElZ 
HVMCR 
15 Erwinia chrysantheroi endoglucanase 
4360 Methanococcus van. 
MVRPOP 6666 Methanococcus van. 
0PP cos 
NGTIA 12 M.gonorrhoea. transformation inhibitory ONA 
SALS4BOP 220 S.aureus phage L54 attL site 
opp ::pLlS 
SAPUBllO 2843 S.aureus plasmid 
SMPAC 4191 Strepto.mutans 
in neo(r) cos 
0PP COS 
SHRPLKA 214 Serratia marcesc.ribos protein Ll1,Ll 
_____ ~Funqi, _______________ _ 
DDAACll 915 Dictyostelium discoiedeum AAC-rich mRNA 
DDACTA32 131 Dictyostelium discoiadeum actin 
opp COS 
oPP cos 
SCAOE3 4116 Saccharomyces cerevisiae C-1-tetrahydrofolate synthase: opp COS 
SCBAFl 1426 Saccharomyces cerevisiae tran!!Scription factor Baf1; opp COS 
SCCPAl 1535 Saccharomyces cerevisiae carbamoyl-phosphate synthetase: opp COS 
SCGCDl 1438 Saccharomyces cerevisiae GCOl gene; 0PP COS 
SCMAL28C 1961 Saccharomyces careviaiae mutant ma12-8cp gene opp COS 
SCHAL6R 1429 Saccharomycea cereviaiae HAL6R gene; 
SCHAT4 294 Saccharomyces cerevisiae mating type; 
SCMYOl 592 S4IIccharomyc.s ceraviaiae myosin-like cdc protein: 
SCPDCl 1401 Saccharomyces cereviaiae pyruvate decarboxylase: 
opp COS 
opp COS 
opp COS 
SCRAD50 3032 Saccharomycea cereviaiaa RAD50 gene; in heptad repe.t region 
SCRAR1 1869 Saccharomyces cereviaiae RARl gene; 
SCSERS 1432 Saccharomyces cerevisiae !!Seryl-tRNA !!Synthetase: 
SCsrLA 
SCsrR2 
244 SaccharOl'lilyces cerevisiae !!Silencer DNA; 
255 Saccharomyces cerevisiae mating type control): 
______ Plants' _______________ _ 
ASPHT3A 231 Avena sativa phytOChrome 
opp gene 
GHLEA 
HVLEU 
843 Soybean lectin transposon like sequence 
911 Barley thiol protease near many reps 
rBGSPOAl 433 Sweet potato sporamin A 
PSELIP 
encoded 
1102 Pea plastid early-light-induced protein chloroplast nuclear 
SCNACT 2112 S.cerevisiae M-acetyltransferase opp COS 
VFVICG 2885· Vicia taba vicilin gene 
______ Invertebrates' __________ _ 
caRR5A 586 • C&enorhabdith briggsae 55 rANA (lkb) knownO in spliced leader! 
CERRS 210 • Caenorhabditis elegans DNA for 55 rRNA knownO in spliced. leader! 
CETUBUB 1631 Caenorhabditis eleqans beta-tubulin knownO 
OHANTPE8 491 D.melanoga!!Ster antennapedia: DMANTPRA 
DMIS116 6632 o.melanoqa!!Ster copia-like element 11.6 int 
DMIS291 6286 D.llDelanogaster transposable element 291 int 
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DMLGL2 5099 D.melanogaster giant larvae; 
DHLGL2 2293 O.Jllelanogaster giant larvae; 
int these two sites 
int are identical 
DMRT412G 2140 Dro!!Sophila retrotransposon 412; 99 at 2154 is also a site 
DNTNIOP 2665 D.nebu10:loa transpo!!Son NIO int 
PFI~ 
DML2AMD 
DH£SPLH1 
229 P. falciPArum interspersed repeat antigen int 
943 Drosophila a-methyldopa hypersensitivity opp intron 
211 • enhancer of split 
DtruBXG5 2619 ultrabithorax promoter 
POiSA 155 P.chabaudi merozoite antigen 
PFSA21 2614 Plasmodium talciparum S-antigen 
281 P .yoelii circum-sporozoite 
281 P .yoelii circwn-!!Sporozoite 
opp noncoding tran!!Script 
opp surface antigen COS 
upstream of poly rep reg-ion 
PYCSP 
PYCSPl 
SPC4X 831 Strongylocentrotus.purpuratus collagen IV 
opp COS 
opp COS 
opp intr 
'fTHIOl 1918 Tetrahy-.ena H4-1 qene and flanks 
______ Vertebrates ___ ~ _________ _ 
GGERSBF 2299 Chicken c-Erb oncoqenic ALV insertion; int 
GGCIA225 525 Chicken alpha-2 collagen I 
GGOVAL 6224 Chicken ovalbWllin gene; 0PP intron G 
GGPEC 310 Chicken ppenolpyr. carboxykina!!Se 
____________ ~~l.' ______________________________ __ 
BTNABGSA 1301 Bovine galactosyltransf. upstream of coding reqion 
OCILIR 1958 Rabbit interleukin 1 pre-cursor 
OCPRG5 134 Rabbit proqe!!Sterone receptor 
SSAPOB2 3621 Pig apolipoprotein B opp exon 
____________ ,Ro~nt!!S' ____________________________ ___ 
MHCrOl 814 Mouse cytochrome P3-450; 
MHCYP245 831 Mouse cytochrome P3-4S0; opp COS 
HMLVPA 
sequences 
2452 Mouse endogenous retrovirus; int, all are nearly identical 
HMERMB56 391 
HMERHB13 390 
HHMLVPA 2452 
HMERU3L6 396 
MHU3LTRB 464 • rep in LTR region 
MMLTRIS 421 has inserted CTR-IS element 
RNRL13 4561 Rat long interspersed repetitive DNA 
MHIRF12 353 House interferon regulatory factor-2 
HHMDMIA 1248· House mdm-l gene 
HMRPL3A 151 House ribosomal protein 132 
HHTPMYOB 143 House beta-tropomyosin 
RNCYP45I 8818 Rat cytochrome P450IIE1; 
RNLCAGl 9681 Rat leukocyte col'tl'll.on antigen; 
RNLCAR 483 Rat leukocyte common antigen; 
RNURIH 1292 Rat uricaoSe 
int, rep 
int 
opp COS 
int near processed gene 
opp COS 
opp COS 
opp pot. glycosylation site 
______ Primates ______________ _ 
GCGAL32 153 G.crassicaudatus short repeated DNA int 
HTLVlRES 589 Human HTLv-I related r'etroviral sequence;int 
HSARGl 162 Human arginase 
HSCALL01 5461 Human lymphoblastic leukemia antigen; 
HSCN2 
HSCN25 
180 Hwun skin collagenase: 
166 Human synovial collagenasa 
HSCOLLR 118 Human coUagenase 
HSCYPJ 1613 Human cytochrome P-4S0j; 
HSENKPH2 140 Human enkephalin gen.; 
opp non-translated mR ~~ 
opp COS 
opp CDS 
HSFBRA 695 Human fibrinogen a-alpha-chain; HSFBRAA opp COS 
HSFBRGG 8515 Hwr.an fibrinogen gamma chain; HSFBRGAB 
HSFIBl 1894 Human fibronectin; 
HSGASTA 4231 Hu.onan gastrin gene; 
HSGCRBR 2823 H\.l!:!.an beta-glucocorticoid receptor: 
HSHLASBA 13320 Human HLA-SB (OP) alpha liene 
HSHLASBA 12953 Human HLA-SB(OP) alpha gene 
HSHLCAB 900 Human alk. myosin light chain I. 
HSMLCIF 900 Human alk. myosin light chain 1 
HSMLCAC 113 Hu.'Mn alkali myosin liqht chain 3; 
HSNMYC 6102 Human n-myc gene; 
HSNMYCOl 4949 Human n-myc gene; 
HSNMYC3 
HSOTC 
50 Human n-myc gene; 
282 ornithine transcarbamy1ase; 
HSUG4PA 491" U4 small nuclear RNA pseudoqene 
int, alternative splicing! 
int Inear Alu) 
int 
opp non -codi ng mRNA 
opp COS 
opp intron 
opp COS 
4724 Nucleic Acids Research, Vol. 18, No. 16 
a 
u a 
9 9 
u-a 
g-c 
g-u 
g-u 
g-c 
u -a 
c a 
HSPKCBl c-g 
a~=~ 
u-a a 
g-c 
c-g c 
u-a u c 
a-u U u-a 
~=~ c-g 
u 9 U a .g.g~.g.a~.u~.c.aa~-a aauucua;-9auucacggug 
9 U a a uuacuguuug agacccaauca 
a
g3U
a 
a a 
a-u 
u-a 
c - g 
::~ MISe13 
u-g 
u-a 
a-u a 
a-u 9 u 
a-u u -9 
u ~:~ g=~ 
a a-u u- a 
u u ??~~':lU?~~~~~~~~aucc 9gauuuuuuga caauuaauua 
a uuauguuugaaauaa 
u u uuuaacaugauua 
ugc C
U9
u 
g-c c - g 
g-c u-9 
9-u GGMYHE U - 3 
u-a 9 g-u 
u a g-c u-g 
u gguauacaauuca aaaaucugucuuugagaaga guuguucgc 
U g u uuauguuuua 
uuuuucuauug 
Figure 3. Three strong candidates for newly identified trans-splicing sites. The 
secondary structures of these predicted sites are very similar the known sites shown 
in Fig. I HSPKCBI is human protein kinase C, MISCI3 is yeast milOchondrial, 
and GGMYHE is chicken embryonic myosin heavy chain. None of these organisms 
are known yet to trans-splice in vivo. 
appear to trans-splice every pre-mRNA [3,6,16,24] and so the 
observation that there are many more splice sites per unit 
sequence in trypanosomes may be simply because they splice a 
higher fraction of their pre-mRNA than do other organisms. 
Secondly, there is a tendency in molecular biology to sequence 
DNA related to previously sequenced DNA and whether this is 
due to the availability of particular probes or common interest 
in certain sequences, the result is that the database does not consist 
of ' independent events' . 
The search was able to distinguish between trans-splicing sites 
and other types of RNA (Table 2). In no cases did the search 
mis-identify tRNA as a trans-splicing site (there is however a 
plausible site which would release tRNA (proline) from a long 
precursor in Spiroplasma, SMTRNA1). Only in two cases (N. 
gruberi 18S rRNA, and L. taraentolae mitochondrial12S rRNA) 
were rRNA genes apparently mistaken for trans-splicing sites 
and no small nuclear RNA known to participate in eis-splicing 
was confused with a trans-splicing site. Both eis- and trans-
splicing RNAs have several similar features, but perform different 
biological functions and the search discriminates between them. 
These three negative controls for RNA structures which appear 
similar but which are functionally distinct underline the ability 
of the search to pick good candidate sites for trans-splicing. 
In an attempt to estimate the background error rate of the 
search, the search was repeated on the strand in the EMBL 
database with the sequence YY(~ 3 C, ± 1 non C)YY 
substituted for the Srn-site. This motif should be biological 
nonfunctional as its Srn-site is destroyed [20] . This search found 
12% as many 'hits' with 6 or 7 of the nonobligatory features 
as did the search using the correct Srn-site. We estimate therefore 
that as many as 80% of the putative hits in Table 2 may be real. 
Similarly, since it is known from T. brucei that other trans-
splicing sites can exist with diverged Srn-sites, and possibly with 
other variations of which we are as yet unaware, the search is 
almost certainly incomplete. 
Phylogenetic distribution of predicted trans-splicing structures 
Even taking into account that 20% of the putative hits in Table 
2 might be false positives, there is still considerable evidence 
that trans-splicing occurs in several groups of organisms in which 
this mechanism has not been previously identified. There are 
groups in which it is not predicted such as the mycoplasmas but 
this may well be due to the small amount of mycoplasma DNA 
in the database. Despite the availability of 38 x 106 base pairs, 
this is actually a very small sample for this type of study. 
However, in general, the phylogenetic distribution of predicted 
trans-splicing structures is sufficiently broad to suggest that trans-
splicing is quite primitive. The question has been raised as to 
whether trans-splicing is an unusual type of splicing that evolved 
in trypanosomes and a few other organism as an adaptive feature 
[6] . We would argue that trypanosomes did not develop trans-
splicing as an adaptation but that they have retained it . 
We observe that in a high number of cases (40), the predicted 
trans-splicing site is proximal to an integration site and that in 
an additional 12 cases, the predicted trans-splicing site is in or 
proximal to repetitive elements or transposons. Other workers 
[25,26] have observed an association between retroposons and 
mini-exons. This association of trans-splicing structures and 
integrating DNA may synergistically accelerate the spread of both 
but perhaps also contributes to the recombination of protein 
coding regions originally carried by the RNA having the 
respective trans-splicing site. 
Strong candidate sites 
It seems appropriate to identify some particularly strong 
candidates for experimental testing. In particular, MID MURFV , 
SMTRNA1, LHDEL, PCTHYSY, GGMYHE, HSPKCBIA, 
and HSTCV A5 contain the catalytic double guanosine [20] 
exactly at an exon boundary . The oxi3locus in yeast (MISC13) 
has a well formed predicted trans-splicing site in the intron aI4 . 
The intron is already known to be important for splicing [27] 
and the following self-splicing group II intron aI5g could be 
divided in vitro to yield two RNAs that trans-spliced in vitro with 
associated trans-branching of excised intron fragments [28]. Refer 
to Fig. 3 for secondary structure diagrams of three of these strong 
candidate sites. Comparison of these with the structures in those 
in Fig. 1 shows how highly similar in structure they are to known 
sites. More examples are given in Table 2; particularly strildng 
are cases in which a trans-splicing site is found in similar positions 
in the same gene from different organisms (class in Table 2) or 
additional evidence is available (Table 2 and notes to Table 2). 
CONCLUSION 
The search identified the five trans-splicing structures from the 
test-set which are undisrupted in the EMBL database and detected 
(with correctly predicted trans-splicing sites) all groups known 
to trans-splice, including Trypanosomes, Nematodes and 
Chloroplasts. Neither rRNAs (two exceptions), tRNAs nor small 
nuclear RNAs involved in eis-splicing were mistakenly identified 
as trans-splicing sites. The search could not identify every known 
trans-splicing site from every species (diverged T.brucei sites, 
two known Chloroplast trans-splicing RNAs and truncated trans-
splicing sites in data base entries were missed). Other RNA 
structures also could promote trans-splicing and might not have 
been been detected. It is also possible that some putative sites 
are in fact pseudogenetic in nature. However, enough new 
candidate trans-splicing sites (even taldng into account a 
background estimate of20% false positives) have been detected 
to suggest that trans-splicing may be much more wide spread 
then previously thought. There are several good candidate 
structures identified in species not yet known to possess trans-
splicing available for experimental testing (Table 2), including 
sites from vertebrates. 
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